SEC Tracker
Get the app

Keenova Therapeutics

Keenova Therapeutics: Ownership stake disclosure (amended)

Schedule 13D/A on Keenova Therapeutics, filed with the SEC on Nov 10, 2026, 4:58 pm ET. Source: the filing on SEC EDGAR.

Ownership stake disclosure by GOLDENTREE ASSET MANAGEMENT LP (amended)

Form
Schedule 13D/A
Filed
Importance
Notable
  1. GoldenTree Master Fund, Ltd. holds 2,510,139 shares
  2. Funds purchased 432,716 shares between Oct 14 and Nov 6
  3. Total shares held by Reporting Persons: 8,821,928
  4. Shares purchased at $89.25 to $90 each

Written from the Schedule 13D/A on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Keenova Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.